Home  >  Products  >  A2M (alpha-2-macroglobulin ) Blocking Peptide (the N terminal of A2M)(100ug)
A2M (alpha-2-macroglobulin ) Blocking Peptide (the N terminal of A2M)(100ug)

A2M (alpha-2-macroglobulin ) Blocking Peptide (the N terminal of A2M)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-A2M Antibody (ARP59224_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59224
Size: 100ug
Weight: 161kDa
Gene: 2
Format: Lyophilized powder
Target: Alpha-2-macroglobulin is a protease inhibitor and cytokine transporter. It inhibits many proteases, including trypsin, thrombin and collagenase. A2M is implicated in Alzheimer disease (AD) due to its ability to mediate the clearance and degradation of A-beta, the major component of beta-amyloid deposits.
Alternative names: CPAMD5; DKFZp779B086; FWP007; S863-7
See Full Product Listings >